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The full Guideline for oxygen use in adults
in healthcare and emergency settings, pub-
lished in Thorax1 provides an update to the
2008 BTS Emergency oxygen guideline.2
The following is a summary of the recom-
mendations and good practice points. The
sections noted to within this summary refer
to the full guideline sections.
EXECUTIVE SUMMARY
Philosophy of the guideline
✓ Oxygen is a treatment for hypoxaemia,
not breathlessness. Oxygen has not been
proven to have any consistent effect on
the sensation of breathlessness in non-
hypoxaemic patients.
✓ The essence of this guideline can be
summarised simply as a requirement for
oxygen to be prescribed according to a
target saturation range and for those
who administer oxygen therapy to
monitor the patient and keep within the
target saturation range.
✓ The guideline recommends aiming to
achieve normal or near-normal oxygen
saturation for all acutely ill patients apart
from those at risk of hypercapnic respira-
tory failure or those receiving terminal
palliative care.
1. Assessing patients
○ For critically ill patients, high concentra-
tion oxygen should be administered
immediately (table 1 and ﬁgure 1) and
this should be recorded afterwards in
the patient’s health record.
○ Clinicians must bear in mind that sup-
plemental oxygen is given to improve
oxygenation, but it does not treat the
underlying causes of hypoxaemia
which must be diagnosed and treated
as a matter of urgency.
○ The oxygen saturation should be
checked by pulse oximetry in all
breathless and acutely ill patients, ‘the
ﬁfth vital sign’ (supplemented by blood
gases when necessary), and the
inspired oxygen concentration should
be recorded on the observation chart
with the oximetry result. (The other
vital signs are pulse rate, blood pres-
sure, temperature and respiratory rate).
○ Pulse oximetry must be available in all
locations where emergency oxygen is
used. Clinical assessment is recom-
mended if the saturation falls by ≥3% or
below the target range for the patient.
○ All critically ill patients outside of a
critical care area (e.g. intensive care
unit (ICU), high dependency unit
(HDU), respiratory HDU), should be
assessed and monitored using a recog-
nised physiological track and trigger
system such as the National Early
Warning Score (NEWS).
2. Target Oxygen prescription
○ Oxygen should be prescribed to
achieve a target saturation of 94–98%
for most acutely ill patients or 88–92%
or patient-speciﬁc target range for
those at risk of hypercapnic respiratory
failure (tables 1–4).
○ Best practice is to prescribe a target
range for all hospital patients at the
time of admission so that appropriate
oxygen therapy can be started in the
event of unexpected clinical deterior-
ation with hypoxaemia and also to
ensure that the oximetry section of
the early warning score (EWS) can be
scored appropriately.
○ The target saturation should be written
(or ringed) on the drug chart or
entered in an electronic prescribing
system (guidance on ﬁgure 1).
3. Oxygen administration
○ Oxygen should be administered by
staff who are trained in oxygen
administration.
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○ These staff should use appropriate devices and
ﬂow rates in order to achieve the target saturation
range (ﬁgure 2).
○ Staff should be trained in the use of a range of
different oxygen delivery devices to ensure
oxygen is delivered safely.
4. Monitoring and maintenance of target saturation
○ Oxygen saturation and delivery system (including
ﬂow rate) should be recorded on the patient’s
monitoring chart.
○ Oxygen delivery devices and ﬂow rates should be
adjusted to keep the oxygen saturation in the
target range. Prompt clinical assessment is
required if oxygen therapy needs to be initiated
or increased due to a falling saturation level.
○ Oxygen should be prescribed and a signature
should be entered on the drug chart on each
drug round.
5. Weaning and discontinuation of oxygen therapy
○ Oxygen should be reduced in stable patients with
satisfactory oxygen saturation.
○ Oxygen should be discontinued once the patient
can maintain saturation within or above the target
range breathing air but the prescription for a target
range should be left in place in case of future
deterioration and to guide early warning scores
(EWS/NEWS).
KEY CHANGES SINCE THE FIRST EDITION OF THIS
GUIDELINE PUBLISHED IN 2008
Methodology
The evidence review methodology has changed from
NICE methodology to the BTS NICE accredited guide-
line production process which is based on the Scottish
Intercollegiate Guideline Network (SIGN) methodology
and adheres to AGREE methodology (see section 1).
Evidence levels and grade of recommendation
These are now in SIGN format (see section 1 and tables 6
and 7).
Evidence base
The evidence base for the guideline has been updated
to August 2013 (and extended to mid-2016 for key refer-
ences). None of the 2008 recommendations have been
challenged by new evidence, but many of the existing
recommendations are supported by new information.
There have been many observational studies but few ran-
domised trials directly relevant to the guideline since
2008.
The remit of the guideline has been extended
The new guideline covers not just emergency oxygen
use but most oxygen use in healthcare settings. It also
covers short-term oxygen use by healthcare workers
Table 1 Critical illnesses requiring high levels of supplemental oxygen (section 8.10)
The initial oxygen therapy is a reservoir mask at 15 l/min pending the availability of reliable oximetry readings.
For patients with spontaneous circulation and a reliable oximetry reading, it may quickly become possible to reduce
the oxygen dose whilst maintaining a target saturation range of 94–98%.
If oximetry is unavailable, continue to use a reservoir mask until definitive treatment is available.
Patients with COPD and other risk factors for hypercapnia who develop critical illness should have the same initial
target saturations as other critically ill patients pending the results of blood gas results after which these patients
may need controlled oxygen therapy with target range 88–92% or supported ventilation if there is severe hypoxaemia
and/or hypercapnia with respiratory acidosis.
Additional comments Recommendations
Cardiac arrest or resuscitation Refer to resuscitation guidelines for choice of delivery
device during active resuscitation.
Give highest possible inspired oxygen concentration
during CPR until spontaneous circulation has been
restored.
Recommendation E1
Shock, sepsis, major trauma, drowning,
anaphylaxis, major pulmonary haemorrhage,
status epilepticus
Also give specific treatment for the underlying
condition.
Recommendations
E2–E4
Major head injury Early tracheal intubation and ventilation if comatose. Recommendation E5
Carbon monoxide poisoning Give as much oxygen as possible using a bag-valve
mask or reservoir mask. Check carboxyhaemoglobin
levels.
A normal or high oximetry reading should be
disregarded because saturation monitors cannot
differentiate between carboxyhaemoglobin and
oxyhaemoglobin, owing to their similar absorbances.
The blood gas PO2 will also be normal in these cases
(despite the presence of tissue hypoxia).
Recommendation E6
COPD, chronic obstructive pulmonary disease; CPR, cardiopulmonary resuscitation; PO2, oxygen tension blood gases.
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Figure 1 Oxygen prescription guidance for acutely hypoxaemic patients in hospital. COPD, chronic obstructive pulmonary
disease; ICU, intensive care unit; NIV, non-invasive ventilation; PO2, oxygen tension; PCO2, arterial or arteriolised carbon dioxide
tension; SpO2, arterial oxygen saturation measured by pulse oximetry.
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outside of healthcare settings, but domiciliary oxygen
use by patients is covered by the BTS Guideline for
home oxygen use in adults.1–3
The scope of the guideline has been widened
The present guideline includes the following new topics
and settings which have been requested by guideline users:
• Postoperative and perioperative care including
patient-controlled analgesia.
• Endoscopy and other procedures requiring conscious
sedation.
• Palliative care settings including hospices.
• Use of helium–oxygen mixtures (Heliox) and nitrous
oxide/oxygen mixtures (Entonox).
• Use of continuous positive airway pressure (CPAP).
• Use of oxygen by healthcare professionals in patients’
homes.
• Use of oxygen by voluntary rescue organisations and
other non-National Health Service ﬁrst responders.
• High ﬂow nasal cannulae (HFNC).
The structure and format of the guideline has been
changed since 2008
The 2008 Guideline was published as a self-contained
document in Thorax.1 Additional educational materials
and other resources including audit tools were
made available on the British Thoracic Society website.
The new guideline exists in two complementary formats.
• A concise guideline which contains recommendations
and good practice points is published here.
• The full guideline including evidence review, physi-
ology overview, illustrations and references is pub-
lished in Thorax1 and is available on the British
Thoracic Society website.
Table 2 Serious illnesses requiring moderate levels of supplemental oxygen if the patient is hypoxaemic (section 8.11)
The initial oxygen therapy is nasal cannulae at 2–6 L/min (preferably) or simple face mask at 5–10 L/min unless
stated otherwise.
For patients not at risk of hypercapnic respiratory failure who have saturation below 85%, treatment should be started
with a reservoir mask at 15 L/min and the recommended initial oxygen saturation target range is 94–98%. If oximetry
is not available, give oxygen as above until oximetry or blood gas results are available. Change to reservoir mask if
the desired saturation range cannot be maintained with nasal cannulae or simple face mask (and ensure that the
patient is assessed by senior medical staff).
If these patients have coexisting COPD or other risk factors for hypercapnic respiratory failure, aim at a saturation of
88–92% pending blood gas results but adjust to 94–98% if the PCO2 is normal (unless there is a history of previous
hypercapnic respiratory failure requiring NIV or IMV) and recheck blood gases after 30–60 min, see table 4.
Additional comments Recommendations
Acute hypoxaemia (cause not yet
diagnosed)
Reservoir mask at 15 L/min if initial SpO2 below 85%,
otherwise nasal cannulae or simple face mask.
Patients requiring reservoir mask therapy need urgent clinical
assessment by senior staff.
Recommendations
D1–D3
Acute asthma
Pneumonia
Lung cancer
Recommendations
F1–F3
Deterioration of lung fibrosis or
other interstitial lung disease
Reservoir mask at 15 L/min if initial SpO2 below 85%,
otherwise nasal cannulae or simple face mask
Recommendation F4
Pneumothorax Needs aspiration or drainage if the patient is hypoxaemic. Most
patients with pneumothorax are not hypoxaemic and do not
require oxygen therapy.
Use a reservoir mask at 15 L/min if admitted for observation.
Aim at 100% saturation (oxygen accelerates clearance of
pneumothorax if drainage is not required).
Recommendations
F5–F6
Pleural effusions Most patients with pleural effusions are not hypoxaemic. If
hypoxaemic, treat by draining the effusion as well as giving
oxygen therapy.
Recommendation F7
Pulmonary embolism Most patients with minor pulmonary embolism are not
hypoxaemic and do not require oxygen therapy.
Recommendation F8
Acute heart failure Consider CPAP or NIV in cases of pulmonary oedema. Recommendations
F9–F10
Severe anaemia The main issue is to correct the anaemia. Most anaemic
patients do not require oxygen therapy.
Recommendations
F11–12
Postoperative breathlessness Management depends on underlying cause. Recommendation J1
COPD, chronic obstructive pulmonary disease; CPAP, continuous positive airway pressure; IMV invasive mechanical ventilation; NIV,
non-invasive ventilation; PCO2, arterial or arterialised carbon dioxide tension; SpO2, arterial oxygen saturation measured by pulse oximetry.
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INTRODUCTION
Aim of the guideline
The key aim of this guideline is to make oxygen use in
emergency and healthcare settings safer, simpler and
more effective. Oxygen is probably the commonest drug
used in the care of patients who present with medical
emergencies. Prior to the publication of the ﬁrst British
Thoracic Society Guideline for Emergency Oxygen Use
in Adult Patients in 2008,1 ambulance teams and emer-
gency department teams were likely to give oxygen to
virtually all breathless or seriously ill patients and also to
a large number of non-hypoxaemic patients with
conditions such as ischaemic heart disease or stroke
based on custom and practice. About 34% of UK ambu-
lance journeys in 2007 involved oxygen use.4 This trans-
lated to about two million instances of emergency
oxygen use per annum by all UK ambulance services,
with further use in patients’ homes, GP surgeries and in
hospitals. Audits of oxygen use and oxygen prescription
have shown consistently poor performance in many
countries, and most clinicians who deal with medical
emergencies have encountered adverse incidents and
occasional deaths due to underuse and overuse of
oxygen.5–11
Table 3 Conditions for which patients should be monitored closely but oxygen therapy is not required unless the patient is
hypoxaemic (section 8.13)
If hypoxaemic, the initial oxygen therapy is nasal cannulae at 2–6 L/min or simple face mask at 5–10 L/min unless
saturation is below 85% (use reservoir mask) or if at risk from hypercapnia (see below).
The recommended initial target saturation range, unless stated otherwise, is 94–98%.
If oximetry is not available, give oxygen as above until oximetry or blood gas results are available.
If patients have COPD or other risk factors for hypercapnic respiratory failure, aim at a saturation of 88–92% pending
blood gas results but adjust to 94–98% if the PCO2 is normal (unless there is a history of respiratory failure requiring
NIV or IMV) and re-check blood gases after 30–60 min, see table 4.
Additional comments Recommendations
Myocardial infarction and acute coronary
syndromes
Most patients with acute coronary artery syndromes are
not hypoxaemic and the benefits/harms of oxygen therapy
are unknown in such cases. Unnecessary use of high
concentration oxygen may increase infarct size.
Recommendation F13
Stroke Most patients who had stroke are not hypoxaemic. Oxygen
therapy may be harmful for non-hypoxaemic patients with
mild-moderate strokes.
Recommendation F14
Hyperventilation or dysfunctional
breathing
Exclude organic illness. Patients with pure hyperventilation
due to anxiety or panic attacks are unlikely to require
oxygen therapy.
Re-breathing from a paper bag may cause hypoxaemia
and is not recommended.
See section 8.13.3
Most poisonings and drug overdoses (see
table 1 for carbon monoxide poisoning)
Hypoxaemia is more likely with respiratory depressant
drugs, give antidote if available, for example, naloxone for
opiate poisoning.
Check blood gases to exclude hypercapnia if a respiratory
depressant drug has been taken. Avoid high blood oxygen
levels in cases of acid aspiration as there is theoretical
evidence that oxygen may be harmful in this condition.
Monitor all potentially serious cases of poisoning in a level
2 or level 3 environment (high-dependency unit or
intensive care unit)
Recommendation F15
Poisoning with paraquat or bleomycin Patients with paraquat poisoning or bleomycin lung injury
may be harmed by supplemental oxygen.
Avoid oxygen unless the patient is hypoxaemic.
Target saturation is 85–88%.
Recommendation F16
Metabolic and renal disorders Most do not need oxygen
(Tachypnoea may be due to acidosis in these patients)
Recommendation F17
Acute and subacute neurological and
muscular conditions producing muscle
weakness
These patients may require ventilatory support and they
need careful monitoring which includes spirometry. If the
patient’s oxygen level falls below the target saturation,
they need urgent blood gas measurements and are likely
to need ventilatory support.
Recommendation G4
Pregnancy and obstetric emergencies Oxygen therapy may be harmful to the fetus if the mother
is not hypoxaemic.
Recommendations
H1–H4
COPD, chronic obstructive pulmonary disease; IMV, invasive mechanical ventilation; NIV, non-invasive ventilation; PCO2, arterial or
arteriolised carbon dioxide tension, SpO2, arterial oxygen saturation measured by pulse oximetry.
O’Driscoll BR, Howard LS, Earis J, et al. BMJ Open Resp Res 2017;4:e000170. doi:10.1136/bmjresp-2016-000170 5
Open Access
group.bmj.com on May 31, 2017 - Published by http://bmjopenrespres.bmj.com/Downloaded from 
Historically, oxygen has been administered for three
main indications of which only one is evidence-based.
First, oxygen is given to correct hypoxaemia because
severe hypoxaemia is clearly harmful to the human
body. Second, oxygen has been administered to ill
patients in case they might become hypoxaemic.
Recent evidence suggests that, if impaired gas
exchange does actually develop, this practice may actu-
ally place patients at increased risk (see full Guideline
section 6.3). Third, a very high proportion of medical
oxygen was administered because most clinicians
believed, prior to 2008, that oxygen can alleviate
breathlessness in most circumstances. However, there is
no good evidence that oxygen relieves breathlessness in
non-hypoxaemic patients. There is evidence of lack of
effectiveness or minimal effectiveness in mildly hypoxae-
mic breathless patients with chronic obstructive pulmon-
ary disease (COPD) and advanced cancer (see full
Guideline sections 6 and 8.11.4).
Against this background, the Standards of Care
Committee of the British Thoracic Society (BTS) estab-
lished a working party in association with 21 other soci-
eties to produce an evidence-based guideline for
emergency oxygen use in the UK. This led to the produc-
tion of the 2008 BTS Guideline for emergency oxygen
use in adult patients which was the world’s ﬁrst guideline
for emergency oxygen therapy.1 This guideline has been
implemented throughout the UK and in many other
countries leading to over 500 citations in the medical lit-
erature up to the end of 2016.
The purpose of the update to the 2008 guideline is to
strengthen the evidence base of the previous guideline
based on revised methodology (which meets criteria
contained in the AGREE II Instrument) and to extend
the evidence base to the end of 2013.12 Additionally, the
remit of the 2008 Guideline has been broadened to
cover several new aspects of oxygen use and a broader
range of locations where oxygen might be used.
Table 4 COPD and other conditions requiring controlled or low-dose oxygen therapy (section 8.12)
Prior to availability of blood gases, use a 24% Venturi mask at 2–3 L/min or 28% Venturi mask at 4 L/min or nasal
cannulae at 1–2 L/min and aim for an oxygen saturation of 88–92% for patients with risk factors for hypercapnia but
no prior history of respiratory acidosis. Adjust target range to 94–98% if the PCO2 is normal (unless there is a history
of previous NIV or IMV) and recheck blood gases after 30–60 min.
Additional comments Recommendations
COPD and other conditions causing
fixed airflow obstruction
(eg bronchiectasis)
May need lower range if acidotic or if known to be
very sensitive to oxygen therapy. Ideally use ‘Alert
cards’ to guide therapy based on previous blood
gas results. Increase Venturi mask flow by up to
50% if respiratory rate is above 30 bpm
Recommendations G1–G2
and section 8.12.1
Exacerbation of cystic fibrosis Admit to regional CF centre if possible, if not
discuss with regional centre or manage according to
protocol agreed with regional CF centre. Ideally use
‘alert cards’ to guide therapy. Increase Venturi mask
flow by by up to 50% if respiratory rate is above
30 bpm
Recommendations G1, G3
and G6
Neuromuscular disease, neurological
condition and chest wall deformity
May require ventilatory support.
Risk of hypercapnic respiratory failure
Recommendations G1, G4
and G6
Morbid obesity Recommendations G1, G5
and G6
CF, Cystic fibrosis; COPD, chronic obstructive pulmonary disease; CPAP, continuous positive airway pressure; IMV, invasive mechanical
ventilation; NIV, non-invasive ventilation; PCO2, arterial or arteriolised carbon dioxide tension; SpO2, arterial oxygen saturation measured by
pulse oximetry.
Table 5 Abbreviations for oxygen devices for use on bedside charts
Add flow in L/min for example, N 2 L/min=nasal oxygen at 2 l/min.
V28 4 l/min=28% Venturi mask at 4 l/min.
RM 15 l/min=reservoir mask at 15 l/min.
A, air
N, nasal cannulae HFN, high flow nasal cannulae
V24, Venturi mask 24% V28, Venturi mask 28% V35, Venturi mask 35%
V40, Venturi mask 40% V60, Venturi mask 60%
H28, humidified O2 28% H40, humidified O2 40% H60, humidified O2 60%
RM, reservoir mask SM, simple face mask TM, tracheostomy mask
CPAP, continuous positive airway pressure NIV, non-invasive ventilation
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Figure 2 Flow chart for oxygen administration on general wards in hospitals. COPD, chronic obstructive pulmonary disease.
EPR, electronic patient record; EWS, early warning score; NEWS, National Early Warning Score; SpO2, arterial oxygen
saturation measured by pulse oximetry.
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Intended users of the guideline and target patient
populations
This guideline is mainly intended for use by all health-
care professionals who may be involved in emergency
oxygen use. This will include ambulance staff, ﬁrst
responders, paramedics, doctors, nurses, midwives, phy-
siotherapists, pharmacists and all other healthcare pro-
fessionals who may deal with ill or breathless patients.
Advice is also provided for ﬁrst responders belonging to
voluntary organisations or other non-NHS bodies.
Information based on this guideline is available on the
BTS website for use in the following situations:
• Hospital use.
• Primary care use.
• Ambulance use (supplemented by Ambulance service
guidance based on this guideline).13
• Use by nursing staff and allied health professions.
These abbreviated versions of the guideline contain
the key recommendations and tables and charts that are
relevant to the particular situation.
Areas covered by this guideline
The guideline addresses the use of oxygen in three
main categories of adult patients in the prehospital and
hospital setting and in other settings such as palliative
care:
• Critically ill or hypoxaemic patients.
• Hypoxaemic patients and patients at risk of hypoxaemia.
• Non-hypoxaemic patients who may beneﬁt from
oxygen (eg, carbon monoxide poisoning).
Areas not covered by this guideline
• Oxygen use in paediatrics: the present guideline
applies only to patients aged >16 years.
• Oxygen use for high altitude activities.
• Oxygen use during air travel.
• Underwater diving and diving accidents.
• Oxygen use in animal experiments.
• Oxygen use in high-dependency units.
• Oxygen use in intensive care units.
• Interhospital level 3 transfers.
• Hyperbaric oxygen.
• Respiratory support techniques including tracheal
intubation, invasive ventilation and non-invasive venti-
lation (NIV) (CPAP is included).
• Self-initiated use of oxygen by patients who have
home oxygen for any reason.
• Ongoing care of hypoxaemic patients at home.
Table 6 SIGN evidence levels
SIGN levels of evidence
1++ High-quality meta-analyses, systematic reviews of RCTs or RCTs with a very low risk of bias
1+ Well-conducted meta-analyses, systematic reviews or RCTs with a low risk of bias
1 Meta-analyses, systematic reviews or RCTs with a high risk of bias
2++ High-quality systematic reviews of case–control or cohort studies
High-quality case–control or cohort studies with a very low risk of confounding or bias and a high probability that the
relationship is causal
2+ Well-conducted case–control or cohort studies with a low risk of confounding or bias and a moderate probability that the
relationship is causal
2− Case–control or cohort studies with a high risk of confounding or bias and a significant risk that the relationship is not
causal
3 Non-analytic studies, eg, case reports, case series
4 Expert opinion
RCT, randomised controlled trial.
Table 7 SIGN grades of recommendation
Grades of recommendations
A At least one meta-analysis, systematic review or RCT rated as 1++, and directly applicable to the target population; or
A body of evidence consisting principally of studies rated as 1+, directly applicable to the target population, and
demonstrating overall consistency of results
B A body of evidence including studies rated as 2++, directly applicable to the target population, and demonstrating overall
consistency of results; or
Extrapolated evidence from studies rated as 1++ or 1+
C A body of evidence including studies rated as 2+, directly applicable to the target population and demonstrating overall
consistency of results; or
Extrapolated evidence from studies rated as 2++
D Evidence level 3 or 4; or
Extrapolated evidence from studies rated as 2+
Good practice points
✓ Recommended best practice based on the clinical experience of the guideline development group
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Limitations of the guideline
This guideline is based on the best available evidence
concerning oxygen therapy. However, a guideline can
never be a substitute for clinical judgement in individ-
ual cases. There may be cases where it is appropriate
for clinicians to act outwith the advice contained in this
guideline because of the needs of individual patients,
especially those with complex or interacting disease
states. Furthermore, the responsibility for the care of
individual patients rests with the clinician in charge of
the patient’s care and the advice offered in this guide-
line must, of necessity, be of a general nature and
should not be relied on as the only source of advice in
the treatment of individual patients. In particular, this
guideline gives very little advice about the management
of the many medical conditions that may cause hypox-
aemia (apart from the speciﬁc issue of managing the
patients’ hypoxaemia). Readers are referred to other
guidelines for advice on the management of speciﬁc
conditions such as COPD, pneumonia, heart failure
etc. Some of these disease-speciﬁc guidelines may
suggest slightly different approaches to emergency
oxygen therapy whereas the present guideline aims to
provide simple all-embracing advice about oxygen
therapy.
Definitions of terms used in the guideline (and normal
values)
Terms such as hypoxaemia and normal values for
oxygen and carbon dioxide in blood gases are provided
in the full Guideline (sections 3–6).
Planned review and updating of the guideline
The 2017 guideline will be reviewed by BTS within
5 years from publication.
Declarations of interest
All members of the Guideline Group made declarations
of interest in line with the BTS Policy, and further
details can be obtained on request from BTS.
SUMMARY OF GUIDELINE RECOMMENDATIONS AND
GOOD PRACTICE POINTS
A. Achieving desirable oxygen saturation ranges in acute illness
(see ﬁgures 1–2 and full Guideline sections 6 and 8)
A1. This guideline recommends aiming to achieve a
normal or near-normal oxygen saturation for all
acutely ill patients apart from those at risk of hyper-
capnic respiratory failure (grade D).
A2. The recommended target saturation range for
acutely ill patients not at risk of hypercapnic respira-
tory failure is 94–98% (grade D).
A3. For most patients with known COPD or other
known risk factors for hypercapnic respiratory
failure (eg, morbid obesity, cystic ﬁbrosis, chest wall
deformities or neuromuscular disorders, or ﬁxed
airﬂow obstruction associated with bronchiectasis),
a target saturation range of 88–92% is suggested
pending the availability of blood gas results (grade
A for COPD, grade D for other conditions).
A4. Most non-hypoxaemic breathless patients do not
beneﬁt from oxygen therapy, but a sudden reduc-
tion of ≥3% in a patient’s oxygen saturation within
the target saturation range should prompt fuller
assessment of the patient (and the oximeter signal)
because this may be the ﬁrst evidence of an acute
illness (grade D).
A5 Since oxygenation is reduced in the supine position,
fully conscious hypoxaemic patients should ideally be
allowed to maintain the most upright posture possible
(or the most comfortable posture for the patient)
unless there are good reasons to immobilise the
patient (eg, skeletal or spinal trauma) (grade D).
B. Clinical and laboratory assessment of hypoxaemia and
hypercapnia (see full Guideline section 7)
B1 Fully trained clinicians should assess all acutely ill
patients by measuring respiratory rate, pulse rate,
blood pressure, temperature and assessing circu-
lating blood volume and anaemia. Expert assist-
ance from specialists in intensive care or from
other disciplines should be sought at an early
stage if patients are thought to have major life-
threatening illnesses and clinicians should be pre-
pared to call for assistance when necessary includ-
ing a call for a 999 ambulance in prehospital care
or a call for the resuscitation team or intensive
care unit (ICU) outreach team in hospital care
(grade D).
B2. Oxygen saturation, ‘the ﬁfth vital sign’, should be
checked by trained staff using pulse oximetry in all
breathless and acutely ill patients (supplemented by
blood gases when necessary) and the inspired oxygen
device and ﬂow rate should be recorded on the obser-
vation chart with the oximetry result (grade D).
B3. Initial clinical assessment and subsequent monitor-
ing of acutely unwell patients should include the
use of a recognised physiological ‘track and trigger’
system, such as the NEWS which may trigger clinical
review due to hypoxaemia, need for supplementary
oxygen or for other reasons (grade D).
B4. For patients who are at risk of hypercapnic respira-
tory failure, it is recommended that the relevant
section of the 2017 NEWS chart should be used.
Points are awarded if the oxygen saturation is below
or above the target range (grade D).
Good practice points for clinical assessment of patients with sus-
pected hypoxaemia
✓ The medical history should be taken when possible in
an acutely breathless patient and may point to the diag-
nosis of a particular acute illness such as pneumonia or
pulmonary embolism or an exacerbation of a chronic
condition such as COPD, asthma or heart failure.
✓ Never discontinue oxygen therapy to obtain an oxim-
etry measurement on room air in patients who
clearly require oxygen therapy.
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✓ Physical examination should be undertaken urgently.
This may provide evidence of a speciﬁc diagnosis
such as heart failure or a large pleural effusion, but it
is common for the cause of breathlessness to remain
undiagnosed until the results of tests such as chest
radiographs are available.
✓ Record arterial oxygen saturation measured by pulse
oximetry (SpO2) and consider blood gas assessment
in patients with unexplained confusion and agitation
as this may be presenting feature of hypoaxaemia
and/or hypercapnia (cyanosis is a difﬁcult physical
sign to record conﬁdently, especially in poor light or
with an anaemic or plethoric patient).
✓ Carefully measure respiratory rate and heart rate
because tachypnoea and tachycardia are more
common than a physical ﬁnding of cyanosis in hypox-
aemic patients.
✓ Appropriate changes should be made to any ‘track
and trigger’ system used to allow for a lower target
range in patients at risk of hypercapnic respiratory
failure. These patients should score no points for sat-
uration if within their target range and they should
score points if the oxygen saturation falls below the
target range or if the saturation rises above the target
range while breathing oxygen. The 2017 update of
the national NEWS chart has a special section for
oximetry measurements for use with patients who
have a target range 88–92% and it is recommended
that the 2017 NEWS chart should be used in all hospi-
tals (see recommendation B4).
✓ The presence of a normal SpO2 does not negate the
need for blood gas measurements especially if the
patient is on supplemental oxygen therapy. Pulse
oximetry will be normal in a patient with normal
oxygen tension (PO2) but abnormal blood pH or
carbon dioxide tension PCO2 or with a low blood
oxygen content due to anaemia. For this reason,
blood gases and full blood count tests are required as
early as possible in all situations where these mea-
surements may affect patient outcomes.
✓ All clinical staff who use oximeters must be trained in
their use and made aware of the limitations of oxim-
etry. (Oximetry is a valuable clinical tool but subject
to artefact and errors of interpretation).
C. Arterial and capillary blood gases (see full Guideline sections
7.1.3 and 8.4 and 8.5)
C1. For critically ill patients or those with shock or
hypotension (systolic blood pressure <90 mm Hg),
the initial blood gas measurement should be
obtained from an arterial sample. For most patients
who require blood gas sampling, either arterial
blood gases or arterialised earlobe blood gases may
be used to obtain an accurate measure of pH and
PCO2. However, the PO2 is less accurate in earlobe
blood gas samples (it underestimates the oxygen
tension by 0.5– 1 kPa) so oximetry should be moni-
tored carefully if earlobe blood gas specimens are
used and a repeat arterial specimen should be
taken if there is any concern about the accuracy of
a capillary sample (grade D).
C2. Local anaesthesia should be used for all arterial
blood gas specimens except in emergencies (grade A).
C3. Blood gases should be checked in the following
situations:
▸ All critically ill patients (Grade D).
▸ Unexpected or inappropriate fall in SpO2 below 94%
in patients breathing air or oxygen or any patient
requiring oxygen to achieve the above target range.
(Allowance should be made for transient dips in sat-
uration to 90% or less in normal individuals during
sleep) (grade D).
▸ Deteriorating oxygen saturation (fall of ≥3%) or increas-
ing breathlessness in a patient with previously stable
chronic hypoxaemia (eg, severe COPD) (grade D).
▸ Most previously stable patients who deteriorate clinically
and require increased fraction of inspired oxygen (FiO2)
to maintain a constant oxygen saturation (grade D).
▸ Any patient with risk factors for hypercapnic respira-
tory failure who develops acute breathlessness, deteri-
orating oxygen saturation, drowsiness or other
symptoms of carbon dioxide retention (grade D).
▸ Patients with breathlessness who are thought to be at
risk of metabolic conditions such as diabetic ketoaci-
dosis or metabolic acidosis due to renal failure
(grade D).
▸ Any other evidence from the patient’s medical condi-
tion that would indicate that blood gas results would
be useful in the patient’s management (eg, an unex-
pected change in ‘track and trigger’ systems such as a
sudden rise of several units in the NEWS score or an
unexpected fall in oxygen saturation of 3% or more,
even if within the target range) (grade D).
Good practice point: patients requiring increased concentration
of oxygen
✓ The requirement for an increased concentration of
oxygen is an indication for urgent clinical reassess-
ment of the patient (and repeat blood gas measure-
ments in most instances, see recommendations W13
and W18 for exceptions).
D. Initial oxygen therapy; initial choice of equipment for
patients who do not have critical illness (see ﬁgures 1–2 and
table 2 and full Guideline sections 8.9 and 10)i
Initial oxygen therapy in critical illness is covered in
the next section.
D1. For acutely breathless patients not at risk of hyper-
capnic respiratory failure who have saturations below
85%, treatment should be started with a reservoir
mask at 15 L/min in the ﬁrst instance. The oxygen
concentration can be adjusted downwards (using
nasal cannulae at 1–6 L/min or a simple face mask
at 5–10 L/min) to maintain a target saturation of
94–98% once the patient has stabilised (grade D).
iFor initial management of patients at risk of hypercapnic respiratory
failure, see recommendations G1 and G2.
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D2. In other cases of acute hypoxaemia without critical
illness or risk factors for hypercapnic respiratory
failure, treatment should be started with nasal can-
nulae (or a simple face mask if cannulae are not tol-
erated or not effective) with the ﬂow rate adjusted to
achieve a saturation of 94–98% (grade D).
D3. If medium-concentration therapy with nasal cannu-
lae or a simple face mask does not achieve the
desired saturation, change to a reservoir mask and
seek senior or specialist advice (grade D).
Good practice point
✓ High ﬂow nasal oxygen using specialised equipment
should be considered as an alternative to reservoir
mask treatment in patients with acute respiratory
failure without hypercapnia. For initial management
of patients at risk of hypercapnic respiratory failure
see recommendations G1 and G2.
E. Oxygen therapy in critical illness (see table 1 and full
Guideline section 8.10)
E1. Use the highest feasible inspired oxygen for ventila-
tion during cardiopulmonary resuscitation. Once spon-
taneous circulation has returned and arterial blood
oxygen saturation can be monitored reliably, aim
for a target saturation range of 94–98% and take an
arterial blood gas sample to guide on-going oxygen
therapy. If the blood gas shows hypercapnic respira-
tory failure, reset the target range to 88–92% or
consider mechanical ventilation (grade D).
E2. In critical illness, including major trauma, sepsis, shock
and anaphylaxis, initiate treatment with a reservoir
mask at 15 L/min and aim at a saturation range of
94–98%. This advice also applies to patients with
critical illness who have risk factors for hypercapnia
pending the results of blood gas measurements and
expert assessment. In patients with spontaneous cir-
culation and a reliable oximetry reading, it may be
possible to maintain a saturation of 94–98% using
lower concentrations of oxygen (grade D).
E3. In cases of drowning, aim at an oxygen saturation of
94–98% once spontaneous circulation is restored
(grade D).
E4. In patients with acute seizures due to epilepsy or other
causes, high-concentration oxygen should be admi-
nistered until a satisfactory oximetry measurement
can be obtained and clinicians should then aim for
an oxygen saturation of 94–98% or 88–92% if the
patient is at risk of hypercapnic respiratory failure
(grade D).
E5. In cases of major head injury, aim at an oxygen satur-
ation of 94–98%. Initial treatment should involve
high-concentration oxygen from a reservoir mask at
15 L/min pending availability of satisfactory blood
gas measurements or until the airway is secured by
intubation (grade D).
E6. In cases of carbon monoxide poisoning, an apparen-
tly ‘normal’ oximetry reading may be produced
by carboxyhaemoglobin, so aim at an oxygen satur-
ation of 100% and use a reservoir mask at 15 L/min
irrespective of the oximeter reading and PaO2 (grade
D).
F. Oxygen therapy for speciﬁc conditions that frequently
require oxygen therapy (see tables 2 and 3 and full Guideline
sections 8.11 and 8.13)
Respiratory conditions with low risk of hypercapnic
respiratory failure:
F1. In acute asthma, aim at an oxygen saturation of 94–
98% (grade D).
F2. In cases of pneumonia who are not at risk of hyper-
capnic respiratory failure, aim at an oxygen satur-
ation of 94–98% (grade D).
F3. In acute breathlessness due to lung cancer, aim at an
oxygen saturation of 94–98% unless there is coexist-
ing COPD. See also ‘Oxygen use in palliative care’
section (grade D).
F4. In acute deterioration of pulmonary ﬁbrosis or other inter-
stitial lung diseases, aim at an oxygen saturation of
94–98% or the highest possible if these targets
cannot be achieved (grade D).
F5. In most cases of pneumothorax, aim at an oxygen sat-
uration of 94–98% if the patient is not at risk of
hypercapnic respiratory failure (grade D).
F6. In patients with pneumothorax having hospital
observation without drainage, the use of high con-
centration oxygen (15 L/min ﬂow rate via reser-
voir mask) is recommended unless the patient is
at risk of hypercapnic respiratory failure (grade
D).
F7. In pleural effusion, aim at an oxygen saturation of
94–98% (or 88–92% if the patient is at risk of hyper-
capnic respiratory failure) (grade D).
F8. In pulmonary embolism, aim at an oxygen saturation
of 94–98% (or 88–92% if the patient is at risk of
hypercapnic respiratory failure) (grade D).
Non-respiratory conditions:
F9. In acute heart failure, aim at an oxygen saturation of
94–98% (or 88–92% if the patient is at risk of hyper-
capnic respiratory failure) (grade D).
F10. Continuous positive airway pressure (CPAP) with
entrained oxygen or high-ﬂow humidiﬁed nasal
oxygen to maintain saturation 94-98% (or 88-92% if
at risk of hypercapnia) should be considered as an
adjunctive treatment to improve gas exchange in
patients with cardiogenic pulmonary oedema who
are not responding to standard treatment (or non-
invasive ventilation (NIV) if there is co-existant hyper-
capnia and acidosis) (grade B).
F11. In anaemia, aim at an oxygen saturation of 94–98%
or 88–92% if the patient is at risk of hypercapnic
respiratory failure (grade D).
Good practice point
✓ Correction of anaemia by blood transfusion should
be based on national guidelines.
F12. In sickle cell crisis and acute chest syndrome, aim for
an oxygen saturation of 94–98% or aim at the sat-
uration level that is usual for the individual patient
(grade D).
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Good practice point regarding sickle cell crisis
✓ Arterial or arterialised capillary blood gases should
be sampled if there is any doubt about the reliability
of oximetry during a sickle cell crisis.
F13. In myocardial infarction and acute coronary syn-
dromes, aim at an oxygen saturation of 94–98% or
88–92% if the patient is at risk of hypercapnic
respiratory failure (grade D).
F14. High concentrations of oxygen should be avoided
in patients with stroke, unless required to maintain
normal oxygen saturation. Aim at an oxygen satur-
ation of 94–98% or 88–92% if the patient is at risk
of hypercapnic respiratory failure (grade D).
Good practice points regarding stroke management
✓ Oxygen saturation should be monitored at least every
4 hours throughout the day and night in patients
with acute stroke and all episodes of hypoxaemia
treated.
✓ Patients with hypoxaemia post-stroke require medical
review to establish and treat the cause.
✓ Oxygen should only be given once the airway has
been cleared and at the lowest concentration neces-
sary to achieve an oxygen saturation of 94–98% or
88–92% if the patient is at risk of hypercapnic respira-
tory failure.
✓ Oxygen should be given via nasal cannulae, unless
there are clear indications for a different oxygen
delivery system.
✓ Patients with stroke and cardiorespiratory comorbid-
ities should be positioned as upright as possible, in a
chair if possible (see recommendation A5).
✓ Patients with a reduced level of consciousness after
stroke should be nursed in the recovery position with
the paralysed side lowest.
Suspected hyperventilation:
Good practice points regarding patients with suspected
hyperventilation
✓ Organic illness must be excluded before making a
diagnosis of hyperventilation.
✓ Patients with a deﬁnite diagnosis of hyperventilation
should have their oxygen saturation monitored.
Those with normal or high SpO2 do not require
oxygen therapy.
✓ Rebreathing from a paper bag can be dangerous and
is NOT advised as a treatment for hyperventilation.
F15. In most poisonings, aim at an oxygen saturation of
94–98% unless the patient is at risk of hypercapnic
respiratory failure (grade D).
F16. In poisoning by paraquat and poisoning by bleomycin,
give oxygen only if the saturation falls below 85%
and reduce or stop oxygen therapy if the satur-
ation rises above 88% (grade D).
F17. In most metabolic and renal disorders, aim at
an oxygen saturation of 94–98% unless the
patient is at risk of hypercapnic respiratory failure
(grade D).
F18. For patients with cluster headaches, oxygen should
be administered using a ﬂow of at least 12 L/min
from a reservoir mask and home oxygen should be
provided (grade D).
G. Patients at risk of hypercapnic respiratory failure (see table 4
and full Guideline section 8.12)
G1. (also A3) For most patients with known COPD or
other known risk factors for hypercapnic respiratory
failure (eg, morbid obesity, cystic ﬁbrosis, chest wall
deformities or neuromuscular disorders or ﬁxed
airﬂow obstruction associated with bronchiectasis),
a target saturation range of 88–92% is suggested
pending the availability of blood gas results (grade
A for COPD, grade D for other conditions).
G2. Some patients with COPD and other conditions are
vulnerable to repeated episodes of hypercapnic
respiratory failure. In these cases, it is recommended
that treatment should be based on the results of pre-
vious blood gas estimations during acute exacerba-
tions. For patients with prior hypercapnic failure
(requiring NIV or intermittent positive pressure ven-
tilation) who do not have an alert card, it is recom-
mended that low-concentration oxygen treatment
should be started using a 24% Venturi mask at 2–
3 L/min (or a 28% Venturi mask at 4 L/min or
nasal cannulae at 1–2 L/min if a 24% mask is not
available) with an initial target saturation of 88–92%
pending urgent blood gas results. These patients
should be treated as a high priority by emergency
services, and the oxygen concentration should be
reduced if the saturation exceeds 92% but increased
if it falls below 88% (grade D).
Good practice points for COPD and other conditions that
may cause hypercapnic respiratory failure
Diagnosis of COPD or suspected exacerbation of COPD:
✓ If the diagnosis is unknown, patients over 50 years of
age who are long-term smokers with a history of
chronic breathlessness on minor exertion such as
walking on level ground and no other known cause
of breathlessness should be treated as having sus-
pected COPD for the purposes of this guideline.
✓ Spirometry should be measured at least once during
hospital admissions for suspected COPD (as per the
National Institute of Health and Care Excellence
(NICE) COPD Guideline).15 Measurement of spirom-
etry may conﬁrm (or exclude) a diagnosis of airﬂow
obstruction, and the FEV1 level is a useful indicator of
disease severity in COPD.
Immediate management of patients with known or sus-
pected COPD:
✓ If the saturation remains below 88% in prehospital
care despite a 28% Venturi mask, change to nasal
cannulae at 2– 6 L/min or a simple face mask at 5 L/
min with target saturation of 88–92% and alert the
emergency department that the patient is to be
treated as a high priority.
✓ Patients with a respiratory rate >30 bpm should have
the ﬂow rate from Venturi masks set above the
minimum ﬂow rate speciﬁed for the Venturi mask
packaging to compensate for the patient’s increased
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inspiratory ﬂow. Increasing the oxygen ﬂow rate into
a Venturi mask does not increase the concentration
of oxygen which is delivered.
✓ Patients with a signiﬁcant likelihood of severe COPD
or other illness that may cause hypercapnic respira-
tory failure should be triaged as very urgent on
arrival in hospital emergency departments and blood
gases should be measured on arrival in hospital.
✓ Prior to availability of blood gas measurements, use a
24% Venturi mask at 2–3 L/min or nasal cannulae at
1–2 L/min or 28% Venturi mask at 4 L/min and aim
for an oxygen saturation of 88–92%
Initial hospital management of patients with exacerba-
tion of COPD:
✓ Patients with exacerbations of COPD need careful
monitoring for hypercapnic respiratory failure with
respiratory acidosis which may develop in the course
of a hospital admission even if the initial blood gases
were satisfactory.
✓ Avoid excessive oxygen use in patients with COPD.
The risk of respiratory acidosis in patients with hyper-
capnic respiratory failure is increased if the PaO2 is
above 10.0 kPa due to previous excessive oxygen use.
✓ If following blood gas measurements the pH and
PCO2 are normal, aim for an oxygen saturation of
94–98% unless there is a history of previous hyper-
capnic respiratory failure requiring NIV or intermit-
tent positive pressure ventilation or if the patient’s
usual oxygen saturation when clinically stable is
below 94% (these patients should have a target range
of 88–92%). Blood gases should be repeated at
30–60 min to check for rising PCO2 or falling pH.
✓ Recheck blood gases after 30–60 min (or if there is
evidence of clinical deterioration) for all patients
with COPD or other risk factors for hypercapnic
respiratory failure even if the initial PCO2 measure-
ment was normal.
✓ If the PCO2 is raised but pH is ≥7.35 ([H+]
≤45 nmol/L) and/or a high bicarbonate level
(>28 mmol/L), the patient has probably got long-
standing hypercapnia; maintain target range of 88–
92% for these patients. Blood gases should be
repeated at 30–60 min to check for rising PCO2 or
falling pH.
✓ If the patient is hypercapnic (PCO2 >6 kPa or 45
mmHg) and acidotic (pH <7.35 or [H+] >45 nmol/L),
start NIV with targeted oxygen therapy if respiratory
acidosis persists for more than 30 min after initial stand-
ard medical management.
✓ For patients using Venturi masks, consider changing
from Venturi mask to nasal cannulae once the
patient has stabilised.
✓ For patients who use long-term home oxygen
(LTOT) for severe COPD, a senior clinician should
consider setting a patient-speciﬁc target range if the
standard range of 88–92% would require inappropri-
ate adjustment of the patient’s usual oxygen therapy
while the patient is in hospital.
Good practice point
Management of hypercapnia or respiratory acidosis
due to excessive oxygen therapy (avoidance of life-threaten-
ing rebound hypoxaemia):
✓ If a patient is suspected to have hypercapnic or
respiratory failure due to excessive oxygen therapy,
the oxygen therapy must be stepped down to the
lowest level required to maintain a saturation range
of 88–92%. This may be achieved using 28% or 24%
oxygen from a Venturi mask or 1–2 L/min via nasal
cannulae depending on oxygen saturation and subse-
quent blood gas measurements.
✓ Sudden cessation of supplementary oxygen therapy
can cause life-threatening rebound hypoxaemia with
a rapid fall in oxygen saturations below the starting
oxygen saturation prior to the start of supplementary
oxygen therapy.
G3. Initial oxygen treatment of cystic ﬁbrosis exacerbations
should be similar to the initial oxygen treatment of
COPD exacerbations with target saturation 88–92%
(see sections 8.12.1–8.12.2) (grade D).
G4. In the initial management of musculoskeletal and
neurological disorders with acute respiratory fail-
ure, or acute-on-chronic respiratory failure, aim at
an oxygen saturation of 88–92% and measure
blood gases to determine if NIV will be required
(grade D).
Good practice point regarding patients with neurological
disorders
✓ Patients with respiratory failure due to neurological
disorders or muscle disease are at high risk of dying
and require urgent assessment to determine if they
are likely to require non-invasive or invasive ventilator
support rather than oxygen therapy. Monitor these
patients with blood gases and regular spirometry
(forced vital capacity). Patients’ wishes regarding this
form of treatment should established as early as pos-
sible in the course of the illness, ideally before an
acute episode has developed.
G5. Morbidly obese patients (body mass index (BMI)
>40 kg/m2), even without evidence of coexistent
obstructive sleep apnoea are at risk of hypoventila-
tion and should be given titrated oxygen to main-
tain a target saturation of 88–92% (grade D).
G6. NIV should be considered for hypercapnic patients
with COPD, CF, neuromuscular disorders or morbid
obesity who are at risk of hypercapnic respiratory
failure if the pH is <7.35 or [H+] >45 nmol/L
(grade D) (see BTS/ICS Guidelines for the
Ventilatory Management of Acute Hypercapnic
Respiratory Failure in Adults).16
H. Oxygen use during pregnancy (see full Guideline section 8.14)
H1. Women who suffer from major trauma, sepsis or
acute illness during pregnancy should receive the
same oxygen therapy as any other seriously ill
patients, with a target oxygen saturation of 94–98%.
The same target range should be applied to women
with hypoxaemia due to acute complications of
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pregnancy (eg, collapse related to amniotic ﬂuid
embolus, eclampsia or antepartum or postpartum
haemorrhage) (grade D).
H2. Women with underlying hypoxaemic conditions
(eg, heart failure) should be given supplemental
oxygen during labour to achieve an oxygen satur-
ation of 94–98% unless they are at risk of hypercap-
nic respiratory failure (target range 88–92%)
(grade D).
H3. Pregnant women who are fully conscious with no
cardiovascular compromise may be managed in the
sitting position or if lying down should use the full
left lateral position (grade D).
H4. Pregnant women above 20 weeks gestation (uterine
fundus at or above the level of the umbilicus) who
are at risk of developing associated cardiovascular com-
promise (eg, trauma and vaginal bleeding) should
be positioned to avoid aortocaval compression by
using left lateral tilt, manual uterine displacement
or by placing them in a full left lateral position
(grade D).
H5. Women who are more than 20 weeks pregnant with
evidence of hypoxaemia associated with reduced con-
sciousness or those requiring respiratory or cardio-
vascular support or cardiopulmonary resuscitation
should be managed with left lateral tilt or manual
uterine displacement (ideally to the left) to improve
cardiac output and oxygen delivery (grade D).
H6. The use of oxygen supplementation during intra-
uterine fetal resuscitation during labour was wide-
spread in the past, but there is no evidence of
beneﬁt. There is weak evidence of harm to the
fetus if supplemental oxygen is given for long
periods during uncomplicated labour. Overall, the
use of oxygen during labour is only required when
there is evidence of maternal hypoxaemia (oxygen
saturation <94%) (grade D).
J. Oxygen use in perioperative care and during procedures
requiring conscious sedation (see full Guideline sections 8.15–
8.16 and 10.11)
J1. Hyperoxaemia is not recommended routinely in the
perioperative and postoperative period to reduce the
incidence of postoperative nausea and vomiting
(grade D).
J2. All procedures involving conscious sedation warrant
routine continuous monitoring of oxygen saturation
via pulse oximetry prior and during the procedure,
and in the recovery period, particularly ﬁbre-optic
bronchoscopy and upper GI endoscopy where a reduc-
tion in arterial oxygen saturation (SaO2) is common,
particularly with concurrent use of sedation (grade C).
J3. Signiﬁcant arterial oxygen desaturation (SpO2<90%
or fall of 4% or more that is prolonged (>1 min
during endoscopy procedures) should be corrected
by supplemental oxygen with the aim of achieving
target oxygen saturations of 94–98%, or 88–92% in
those at risk of hypercapnic respiratory failure
(grade D).
J4. Complicated upper GI endoscopy or procedures in
patients with cardiorespiratory comorbidity are espe-
cially likely to lead to hypoxaemia and may also lead
to hypercapnia, especially if the patient is heavily
sedated. It is recommended that blood gases should
be measured if such patients should require prolonged
oxygen administration. The routine administration of
oxygen is not recommended as it may delay the recog-
nition of respiratory failure (grade D).
J5. Constant clinical assessment of the patient is crucial
at all stages of conscious sedation procedures and
monitoring of capnography or transcutaneous
carbon dioxide levels may be a useful adjunct to
identify early respiratory depression (grade D).
J6. During the recovery period after procedures requir-
ing conscious sedation, supplemental oxygen should
be titrated to achieve target saturations of 94–98% in
most patients and 88–92% in those at risk of hyper-
capnic respiratory failure (see 10.5.1) (grade D).
Good practice points related to oxygen use in perioperative care
✓ A target saturation of 94–98% is recommended for
most surgical patients except those at risk of hyper-
capnic respiratory failure when a range of 88–92%
should be achieved.
✓ Pulse oximetry monitoring is recommended for post-
operative patients despite the lack of evidence from
randomised studies.
✓ Patients using patient-controlled analgesia (PCA) should
have two-hourly oximetry observations because of the
risk of hypoxaemia. Oxygen should be administered
to keep patients within the appropriate target satur-
ation range.
✓ A target saturation of 94–98% is advised in most
patients having PCA except those at risk of hypercap-
nic respiratory failure when a range of 88–92%
should be achieved.
✓ There is conﬂicting evidence concerning the balance
of potential beneﬁts and risks of perioperative hyperoxae-
mia to reduce the risk of surgical site infection in elective
surgery and there is no evidence for this practice in
patients having emergency surgical procedures. More
trials are required for speciﬁc procedures, and more
information is required concerning long-term mortal-
ity risks to patients with cancer. In the meantime,
oxygen should not be used for this indication outside
of clinical trials.
K. Oxygen use in palliative care (see full Guideline section 8.17)
K1. Oxygen use in palliative care patients should be
restricted to patients with SpO2 consistently <90%
or patients who report signiﬁcant relief of breath-
lessness from oxygen. In non-hypoxaemic patients,
opioids and non-pharmacological measures should
be tried before oxygen (grade B).
K2. In general, there is no role for the monitoring of
oxygen saturation or PaO2 in comfort-focused care
in the last few days of life. If the patient appears
comfortable, oxygen levels are irrelevant and
should not inﬂuence care (grade D).
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Good practice points related to oxygen use in palliative care
Oxygen therapy for the symptomatic relief of breath-
lessness in palliative care patients is more complex than
the simple correction of hypoxaemia. Consider the fol-
lowing issues:
✓ Consider early involvement of palliative care specia-
lists and physiotherapists.
✓ As breathlessness is a multifactorial sensation—a com-
prehensive assessment of contributing factors (such
as anxiety) should be carried out.
✓ Low-dose opioids should be considered because they
are effective for the relief of breathlessness in pallia-
tive care patients.
✓ A trial of a handheld fan to help relieve breathless-
ness is recommended prior to trial of oxygen.
✓ Oxygen use has to be tailored to the individual and a
formal assessment made of its efﬁcacy for reducing
breathlessness and improving quality of life for that
person.
✓ Oxygen therapy should not be continued in the
absence of patient beneﬁt or where its disadvantages
(eg, discomfort of masks or nasal cannulae, drying of
mucous membranes) outweigh any likely symptom-
atic beneﬁt.
L. Mixtures of oxygen with other gases (Heliox and Entonox)
Use of helium–oxygen mixtures (Heliox) (see full
Guideline section 8.18):
L1. There is insufﬁcient evidence to support the use of
Heliox either as an inhaled gas or as the driving gas
for nebuliser therapy in adult patients with acute
exacerbations of asthma or acute exacerbations of
COPD (AECOPD) except as part of randomised
clinical trials or in exceptional circumstances
(grade D).
L2. A therapeutic trial of Heliox is reasonable in
patients with mechanical upper airway obstruction
or postoperative stridor (grade D).
L3. Heliox use for patients with asthma or COPD should
be considered only in clinical trials or in specialist
hands for severe exacerbations that are not responding
to standard treatment (and in COPD patients where
there are contraindications to intubation) (grade D).
M. Use of nitrous oxide/oxygen mixtures (Entonox) for anal-
gesia (see full Guideline section 9.11)
M1. The use of Entonox gas mixture for analgesia
should be avoided if possible in patients at risk of
hypercapnic respiratory failure (grade D).
N. CPAP and humidiﬁed high-ﬂow nasal oxygen
Use of CPAP in the perioperative period and for pul-
monary oedema (see online section 8.19):
N1. Patients with diagnosed sleep-disordered breathing
established on CPAP undergoing surgery should
bring their machines with them and use them in
the preoperative and postoperative period. If
adequate saturations are not achieved despite CPAP
therapy, then assess for worsening ventilation with
blood gases and oxygen should be entrained to
achieve a saturation of 88–92% (grade D).
N2. CPAP with entrained oxygen to maintain saturation
94–98% should be considered to be an adjunctive
treatment to improve gas exchange in patients with
cardiogenic pulmonary oedema who are not
responding to standard treatment in hospital care
or in prehospital care (grade B).
Good practice point, high-ﬂow humidiﬁed nasal oxygen via
nasal cannulae
✓ High ﬂow nasal oxygen should be considered as a
potentially superior alternative to reservoir mask
treatment in patients with acute respiratory failure
without hypercapnia.ii
P. Patients with tracheostomy or laryngectomy (see section 10.3)
P1. When oxygen is required by patients with prior
tracheostomy or laryngectomy, a tracheostomy mask
(varying the ﬂow as necessary) should achieve the
desired oxygen saturation (tables 1–4). An alterna-
tive delivery device, usually a T-piece device ﬁtted
directly to the tracheostomy tube, may be necessary
if the patient deteriorates (grade D).
Q. Humidiﬁcation of oxygen (see section 10.2)
Q1. Humidiﬁcation is not required for the delivery of
low-ﬂow oxygen (mask or nasal cannulae) or for the
short-term use of high-ﬂow oxygen. It is not therefore
required in prehospital care. Pending the results of
clinical trials, it is reasonable to use humidiﬁed
oxygen for patients who require high-ﬂow oxygen
systems for more than 24 hours or who report upper
airway discomfort due to dryness (grade D).
Q2. In the emergency situation, humidiﬁed oxygen use
can be conﬁned to patients with tracheostomy or
an artiﬁcial airway although these patients can be
managed without humidiﬁcation for short periods
of time (eg, ambulance journeys) (grade D).
Q3. Humidiﬁcation may also be of beneﬁt to patients
with viscous secretions causing difﬁculty with expec-
toration. This beneﬁt can be achieved using nebu-
lised normal saline (grade D).
Q4. Bubble bottles which allow a stream of oxygen to
bubble through a container of water should not be
used because there is no evidence of a clinically sig-
niﬁcant beneﬁt but there is a risk of infection
(grade D).
Good practice points related to humidiﬁed oxygen therapy
✓ Consider use of a large volume oxygen humidiﬁer
device for patients requiring high-ﬂow rates or longer
term oxygen, especially if sputum retention is a clin-
ical problem.
✓ In the absence of an artiﬁcial airway, the decision
to humidify supplemental oxygen needs to be
made on an individual basis but this practice is not
evidence-based.
R. Driving gas for nebulised treatments (see section 10.4)
R1. For patients with asthma, nebulisers should be
driven by piped oxygen or from an oxygen cylinder
iiThe preﬁx O is not in use for recommendations.
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ﬁtted with a high-ﬂow regulator capable of deliver-
ing a ﬂow rate of >6 L/min. The patient should be
changed back to his/her usual oxygen mask or can-
nulae when nebuliser therapy is complete. If the
cylinder does not produce this ﬂow rate, an air-
driven nebuliser (with electrical compressor)
should be used with supplemental oxygen by nasal
cannulae at 2–6 L/min to maintain an appropriate
oxygen saturation level (grade D).
R2. When nebulised bronchodilators are given to
patients with hypercapnic acidosis, they should be
given using an ultrasonic nebuliser or else a jet nebu-
liser driven by compressed air and, if necessary, sup-
plementary oxygen should be given concurrently by
nasal cannulae to maintain an oxygen saturation of
88–92%. The same precautions should be applied to
patients who are at risk of hypercapnic respiratory
failure prior to the availability of blood gas results
and the oxygen saturation should be monitored con-
tinuously during treatment. Once the nebulised
treatment is completed for patients at risk of hyper-
capnic respiratory failure, their previous targeted
oxygen therapy should be reinstituted (grade D).
Good practice points
Do not allow hypoxaemia to occur while administering
nebulised treatments.
✓ For hypoxaemic patients, oxygen therapy should con-
tinue during nebulised treatments.
Driving gas for nebulised treatment in ambulances:
✓ During treatment by ambulance staff, oxygen-driven
nebulisers should be used for patients with asthma
and may be used for patients with COPD in the
absence of an air-driven compressor system. If oxygen
is used for patients with known COPD, its use should
be limited to 6 min. This will deliver most of the neb-
ulised drug dose but limit the risk of hypercapnic
respiratory failure (section 10.4). Ambulance services
are encouraged to explore the feasibility of introdu-
cing battery powered, air-driven nebulisers or port-
able ultrasonic nebulisers.
S. Prescribing oxygen therapy (see full Guideline section 11)
S1. Every healthcare facility should have a standard
oxygen prescription document or, preferably, a
designated oxygen section on all drug prescribing
cards or guided prescription of oxygen in electronic
prescribing systems (grade D).
S2. A prescription for oxygen should always be provided,
except in sudden illness when it must be started imme-
diately and documented retrospectively (grade D).
S3. Doctors and other prescribers should prescribe
oxygen using a target saturation range (sections 8, 9
and 11) and sign the drug chart or electronic pre-
scribing order (grade D).
S4. An oxygen target saturation range should be pre-
scribed for all patients who are admitted to hospital.
This will ensure that every patient will receive appro-
priate oxygen therapy if it should be required. It will
also ensure that all clinicians are aware of the
appropriate oxygen target range for every patient
under their care (grade D).
Good practice points related to prescribing and administering
oxygen therapy to patients
✓ Oxygen should be prescribed on the drug chart or elec-
tronic prescribing system using a target saturation range.
✓ Oxygen should be prescribed to a target saturation
range rather than prescribing a ﬁxed concentration
of oxygen or fraction of inspired oxygen (see recom-
mendations A1, A2, A4 and A5)
✓ In most emergency situations, oxygen is given to
patients immediately without a formal prescription.
The lack of a prescription should never preclude
oxygen being given when needed in an emergency
situation. However, a subsequent written record must
be made of what oxygen therapy has been given to
every patient in a similar manner to the recording of
all other emergency treatment.
✓ If a patient has an oxygen alert card, initial oxygen
therapy should be based on the guidance on the
card until the results of blood gases are available.
T. Monitoring and adjusting oxygen therapy (see full
Guideline sections 9–11)
T1. Pulse oximetry must be available in all locations
where emergency oxygen is being used by health-
care professionals (see also the limitations of using
pulse oximetry section 7.1.2) (grade D).
T2. All documents which record oximetry measure-
ments or blood gas results should state whether the
patient is breathing air or a speciﬁed oxygen deliv-
ery device and ﬂow rate using the abbreviations
shown in table 5 (grade D).
T3. In all situations where repeated blood gas measure-
ments are required, they should be measured as
soon as possible, usually within 30 min of any treat-
ment change, to determine if the proposed target
saturations are appropriate. Consider the use of an
indwelling arterial catheter if multiple samples are
likely to be required (grade D).
T4. Adjustments should only be made by registered staff
who have been trained to administer oxygen. If the
oxygen saturation falls below the prespeciﬁed
range, the concentration of oxygen should be
increased; if the saturation rises above this range,
the oxygen concentration should be reduced. If the
monitoring of oxygen saturation is performed by
unregistered staff (eg, healthcare assistants), there
must be a clear protocol in place which requires
that they should inform staff who are trained to
administer oxygen if the oxygen saturation is above
or below the target saturation (grade D).
Good practice points related to administration of oxygen therapy
✓ For hypoxaemic patients, oxygen therapy should con-
tinue during other treatments such as nebulised
therapy. Clinicians should assess the clinical status of
the patient prior to prescribing oxygen and the
patient’s condition should be reassessed frequently
during oxygen use (see recommendations B1–B3).
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✓ The administering healthcare professional should
note the oxygen saturation before starting oxygen
therapy wherever possible but never discontinue or
delay oxygen therapy for seriously ill patients (see
recommendation B2).
✓ The healthcare professional should start oxygen
therapy using an appropriate delivery system and ﬂow
rate as speciﬁed in sections 8–10 of this guideline.
The target oxygen saturation should be documented
on the respiratory section of the observation chart.
✓ Whenever possible, patients should be given an
oxygen information sheet (example in web appendix
6 on the BTS website).
✓ Staff should check the oxygen supply and connec-
tions on a regular basis because there have been
serious incidents due to disconnection or misconnec-
tion of oxygen supplies.
✓ Staff must ensure that adequate oxygen is provided
during transfers and while patients are in diagnostic
departments. Additionally, oxygen saturation should
be monitored continuously for seriously ill patients
who require escorted transfers. This is because there
have been serious incidents involving accidental dis-
continuation of oxygen or cylinders running out
during interward transfers or transfers to other
departments such as for X-rays.
U. Weaning and discontinuation of oxygen therapy
U1. Lower the oxygen concentration if the patient is
clinically stable and the oxygen saturation is above
the target range or if it has been in the upper zone
of the target range for some time (usually 4–
8 hours) (grade D).
U2. If the target saturation is maintained, the new deliv-
ery system and ﬂow should be continued. Repeat
blood gas measurements are not required. If the
patient is stable, the process can be repeated and
the patient can eventually be weaned off oxygen
(see section 12) (grade D).
U3. Most stable convalescent patients will eventually be
stepped down to 2 L/min via nasal cannulae prior
to cessation of oxygen therapy. Patients at risk of
hypercapnic respiratory failure may be stepped
down to 1 L/min (or occasionally 0.5 L/min) via
nasal cannulae or a 24% Venturi mask at 2 L/min
as the lowest oxygen concentration prior to cessa-
tion of oxygen therapy (grade D).
U4. Oxygen therapy should be stopped once a patient
is clinically stable on low-concentration oxygen, and
the oxygen saturation is within the desired range
on two consecutive observations (but the prescrip-
tion for a target saturation range should remain
active in case of future deterioration). It may be
appropriate to alter the target range following
senior review in patients with chronic cardiopul-
monary disease who either have saturations <94%
when stable or in whom it is deemed sensible to
discharge from hospital with saturations <94%
pending an outpatient oxygen assessment. Oxygen
should also be stopped if the patient has come to
the end of a written protocol of timed oxygen (eg,
postoperatively) (grade D).
U5. Oxygen saturation on air should be monitored for
5 min after stopping oxygen therapy. If it remains
in the desired range, it should be rechecked at
1 hour (grade D).
U6. If the oxygen saturation and physiological ‘track
and trigger’ score (eg, NEWS) is satisfactory at
1 hour, the patient has safely discontinued oxygen
therapy. However, saturation and physiology should
continue to be monitored on a regular basis
according to the patient’s underlying clinical condi-
tion (grade D).
U7. If the saturation falls below the patient’s target range
on stopping oxygen therapy, restart the lowest con-
centration that maintained the patient in the target
range and monitor for 5 min. If this restores the sat-
uration into the target range, continue oxygen
therapy at this level and attempt discontinuation of
oxygen therapy again at a later date provided the
patient remains clinically stable (grade D).
U8. If a patient requires oxygen therapy to be restarted
at a higher concentration than before to maintain
the same target saturation range, the patient
should have a clinical review to establish the cause
for this deterioration (grade D).
U9. Some patients may have episodic hypoxaemia (eg,
after minor exertion or due to mucus plugging)
after they have safely discontinued oxygen therapy.
An on-going prescription for a target saturation
range will allow these patients to receive oxygen as
the need arises but transient asymptomatic desatur-
ation does not require correction (grade D).
V. Practical aspects of oxygen use in prehospital and hospital
care and use of oxygen alert cards (see full Guideline sections
9–11)
V1. Emergency oxygen should be available in primary
care medical centres, preferably using oxygen cylin-
ders with integral high-ﬂow regulators. Alternatively,
oxygen cylinders ﬁtted with high-ﬂow regulators
(delivering up to 15 L/min) must be used to allow
use with reservoir masks (grade D).
V2. Healthcare organisations should take measures to
eliminate the risk of oxygen tubing being con-
nected to the incorrect wall oxygen outlet or to
outlets that deliver compressed air or other gases
instead of oxygen. Air ﬂow metres should be
removed from the wall sockets or covered with a
designated air outlet cover when not in use. Special
care should be taken if twin oxygen outlets are in
use (grade D).
Good practice points related to practical aspects of oxygen
therapy
Assessment and immediate oxygen therapy:
✓ Chronically hypoxaemic patients with a clinical
exacerbation associated with a 3% or greater fall in
oxygen saturation on their usual oxygen therapy
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should usually be assessed in hospital with blood gas
estimations. PaO2 of <7 kPa equates to SpO2 below
∼85%.
✓ The initial oxygen therapy to be used in the various
clinical situations is given in tables 1–4.
✓ If there is a clear history of asthma or heart failure or
other treatable illness, appropriate treatment should
be instituted in accordance with guidelines or stand-
ard management plans for each disease.
✓ The oxygen saturation should be monitored continu-
ously until the patient is stable or arrives at hospital
for a full assessment. The oxygen concentration
should be adjusted upwards or downwards to main-
tain the target saturation range.
✓ In most emergency situations, oxygen is given to
patients immediately without a formal prescription
or drug order. The lack of a prescription should
never preclude oxygen being given when needed in
an emergency situation. However, a subsequent
written record must be made of what oxygen
therapy has been given to every patient (in a similar
manner to the recording of all other emergency
treatment).
✓ General practitioners or ﬁrst responders visiting a
patient’s home should carry a portable pulse oxim-
eter to assess hypoxaemia and guide use of oxygen if
available and should call emergency services if hypox-
aemia or other serious illness is suspected.
✓ Those attending patients as an emergency in rural or
remote areas should consider carrying a portable
oxygen cylinder as part of their emergency equipment.
Oxygen alert cards for patients with hypercapnic
respiratory failure:
✓ Patients with COPD (and other at-risk conditions)
who have had an episode of hypercapnic respiratory
failure should be issued with an oxygen alert card
and with a 24% or 28% Venturi mask. They should
be instructed to show the card to the ambulance
crew and emergency department staff in the event of
an exacerbation.
✓ Oxygen alert cards with agreed content can be
obtained via the BTS website.
✓ The content of the alert card should be speciﬁed by
the physician in charge of the patient’s care, based
on previous blood gas results.
✓ The primary care team and ambulance service
should also be informed by the hospital COPD team
that the patient has had an episode of hypercapnic
respiratory failure and carries an oxygen alert card.
The home address and ideal oxygen concentration
or target saturation ranges of these patients can be
ﬂagged in the ambulance control systems and infor-
mation disseminated to ambulance crews when
required.
✓ When possible, out-of-hours services providing emer-
gency primary care services should be informed by
the hospital COPD team or by the primary care team
that the patient has had an episode of hypercapnic
respiratory failure and carries an oxygen alert card.
Use of oxygen in these patients will be guided by the
instructions on the alert card or by a Patient Speciﬁc
Protocol which can be shared by hospital teams, the
ambulance service and the primary care team.
W. Practical aspects of oxygen dispensing, documentation and
monitoring
W1. Registered nurses and others who dispense drugs
in hospitals should sign the drug chart or elec-
tronic prescribing record at every drug round and
check that the patient is receiving oxygen therapy.
This is to check that the patient is within the target
saturation and also to check whether weaning and
discontinuation should be instituted (grade D).
W2. Most patients are prescribed an oxygen target
range. If patients are on air at the time of the drug
round, registered nurses should sign the drug chart
using a code such as ‘A’ for air and the observation
chart should also be ﬁlled in using the code A for
air (see table 5 and ﬁgure 19 in the full guideline)
(grade D).
W3. All patients should have their oxygen saturation
observed for at least 5 min after starting oxygen
therapy or for patients who require an increased
concentration of oxygen and after oxygen therapy
has been decreased or stopped (grade D).
W4. If the oxygen saturation is above the target saturation
range and the patient is stable, the delivery system or
oxygen ﬂow rate should be modiﬁed to return the
saturation to within the target range (grade D).
W5. Patients who have a target saturation of 88–92%
should have their blood gases measured within
30–60 min. This is to ensure that the carbon
dioxide level is not rising. This recommendation
also applies to those who are at risk of developing
hypercapnic respiratory failure but who have a
normal PCO2 on the initial blood gas measurement
(grade D).
W6. Stable patients whose oxygen saturation is within
their target saturation range of 94–98% do not
need repeat blood gas measurements within
30–60 min if there is no risk of hypercapnic respira-
tory failure and acidosis and may not need any
further blood gas measurements unless there should
be further deterioration including symptoms or
signs of possible hypercapnia (grade D).
W7. Stable patients on oxygen treatment should have
SpO2 and physiological variables (eg, NEWS) mea-
sured four times a day (grade D).
W8. In those who have signs of critical illness (eg,
NEWS score 7 or above), oxygen saturation should
be monitored continuously and the patient may
require level 2 or level 3 care on a high-
dependency unit or critical care unit (grade D).
W9. If the patient is clinically stable and the oxygen sat-
uration is within the target range, treatment should
be continued (or eventually lowered) depending
on the clinical situation (grade D).
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W10. Oxygen therapy should be increased if the saturation
is below the desired range and decreased if the sat-
uration is above the desired range (and eventually
discontinued as the patient recovers) (grade D).
W11. The new saturation (and the new delivery
system) and ﬂow rate should be recorded on the
patient’s observation chart after 5 min of treat-
ment at the new oxygen concentration. Each
change should be recorded by the clinician
trained to administer oxygen by signing the
observation chart (only changes should be
signed for) (grade D).
W12. Repeat blood gas measurements are not required
for stable patients who require a reduced concentra-
tion of oxygen (or cessation of oxygen therapy) to
maintain the desired target saturation (grade D).
W13. Patients with no risk of hypercapnic respiratory
failure do not always need repeat blood gas mea-
surements after an increase in oxygen concentra-
tion. However, the patient requires clinical review
to determine why the oxygen saturation has fallen
(grade D).
W14. Patients at risk of hypercapnic respiratory failure
(usually those with a target range of 88–92%; see
table 4) require repeat blood gas assessment 30–
60 min after an increase in oxygen therapy (to
ensure that the carbon dioxide level is not rising)
(grade D).
W15. For patients with no risk of hypercapnic respira-
tory failure, monitoring by pulse oximeter is sufﬁ-
cient (repeated blood gases not required)
provided the patient is clinically stable and the
oxygen saturation remains in the desired range,
usually 94–98% (grade D).
W16. If a patient’s oxygen saturation is lower than the
prescribed target range, ﬁrst check all aspects of
the oxygen delivery system and the oximeter
device for faults or errors (grade D).
W17. If a patient’s oxygen saturation is consistently
lower than the prescribed target range, there
should be a medical review and the oxygen
therapy should be increased according to an
agreed written protocol (grade D).
W18. If the oxygen saturation fails to rise following
5–10 min of increased oxygen therapy or if there is
clinical concern following medical review, then blood
gas measurements should be repeated (grade D).
X. Training in oxygen prescribing and use
X1. All clinicians prescribing oxygen should have
appropriate training and access to written or elec-
tronic oxygen prescribing guidelines based on this
national guideline (grade D) (see online
appendices 7 and 8).
X2. Every hospital should have a training programme to
ensure that clinical staff are familiar with the hospital’s
oxygen administration policies. In view of the high
number of adverse incidents related to oxygen
therapy, it is recommended that all acute trusts should
include basic training in oxygen use in the mandatory
training programmes for all clinical staff (grade D).
Healthcare providers need to use clinical judge-
ment, knowledge and expertise when deciding
whether it is appropriate to apply recommendations
for the management of patients. The recommenda-
tions cited here are a guide and may not be appro-
priate for use in all situations. The guidance
provided does not override the responsibility of
healthcare professionals to make decisions appropri-
ate to the circumstances of each patient, in consult-
ation with the patient and/or their guardian or carer.
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